27 results
8-K
EX-3.1
DMAC
DiaMedica Therapeutics Inc.
18 May 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
) with respect to the background, qualifications, stock ownership and independence of such Proposed Nominee and (b) a written representation and agreement … shareholder’s understanding of the independence, or lack thereof, of such nominee. Such information will be considered timely if provided to the Company
8-K
EX-1.1
zxi1ftx8
10 Aug 20
DiaMedica Announces Pricing of $20 Million Public Offering of Common Shares
12:00am
8-K
EX-1.1
gllf67swi5gk73nr
13 Feb 20
DiaMedica Announces Pricing of Public Offering of Common Shares
4:31pm
DEF 14A
a7s7 koxsgl
8 Apr 19
Definitive proxy
6:04am
PRE 14A
y99hlgorha3upaiv9
20 Mar 19
Preliminary proxy
4:31pm
10-K
f2jxny ko
19 Mar 19
Annual report
4:58pm
8-K
EX-1.1
2nos6mb
11 Dec 18
Diamedica Announces Pricing of Initial Public Offering and Nasdaq Listing
4:06pm
424B4
m92zqsfaa
10 Dec 18
Prospectus supplement with pricing info
4:50pm